Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

DEPO-TESTOSTERONE

TESTOSTERONE CYPIONATE

Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview DEPO-TESTOSTERONE is listed in Drugs@FDA under application 085635 (ANDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient TESTOSTERONE CYPIONATE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor PFIZER Submission history Latest submission status date: 2025-07-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview DEPO-TESTOSTERONE is listed in Drugs@FDA under application 085635 (ANDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient TESTOSTERONE CYPIONATE Form and strength INJECTABLE;INJECTION - 50MG/ML Sponsor PFIZER Submission history Latest submission status date: 2025-07-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.